Literature DB >> 31073702

Post-infection irritable bowel syndrome in the tropical and subtropical regions: Vibrio cholerae is a new cause of this well-known condition.

Uday C Ghoshal1, M Masudur Rahman2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31073702     DOI： 10.1007/s12664-019-00959-2

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN： 0254-8860


× No keyword cloud information.
  78 in total

1.  Cholera toxin promotes B cell isotype differentiation.

Authors:  N Lycke; W Strober
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

2.  Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study.

Authors:  Fermín Mearin; Marc Pérez-Oliveras; Antonia Perelló; Jaume Vinyet; Anabel Ibañez; Jordi Coderch; Mónica Perona
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

3.  Factors associated with the development of post-infectious functional gastrointestinal diseases: does smoking play a role?

Authors:  Sally D Parry; J Roger Barton; Mark R Welfare
Journal:  Eur J Gastroenterol Hepatol       Date:  2005-10       Impact factor: 2.566

4.  Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico.

Authors:  Pablo C Okhuysen; Zhi Dong Jiang; Lily Carlin; Charles Forbes; Herbert L DuPont
Journal:  Am J Gastroenterol       Date:  2004-09       Impact factor: 10.864

5.  5-Hydroxytryptamine and cholera secretion: a histochemical and physiological study in cats.

Authors:  O Nilsson; J Cassuto; P A Larsson; M Jodal; P Lidberg; H Ahlman; A Dahlström; O Lundgren
Journal:  Gut       Date:  1983-06       Impact factor: 23.059

6.  Interactions of intestinal mediators in the mode of action of cholera toxin.

Authors:  J W Peterson; Y Lu; S Duncan; J Cantu; A K Chopra
Journal:  J Med Microbiol       Date:  1994-07       Impact factor: 2.472

7.  Human Gut Microbiota Predicts Susceptibility to Vibrio cholerae Infection.

Authors:  Firas S Midani; Ana A Weil; Fahima Chowdhury; Yasmin A Begum; Ashraful I Khan; Meti D Debela; Heather K Durand; Aspen T Reese; Sai N Nimmagadda; Justin D Silverman; Crystal N Ellis; Edward T Ryan; Stephen B Calderwood; Jason B Harris; Firdausi Qadri; Lawrence A David; Regina C LaRocque
Journal:  J Infect Dis       Date:  2018-07-13       Impact factor: 7.759

8.  Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation.

Authors:  E Muñoz; A M Zubiaga; M Merrow; N P Sauter; B T Huber
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

9.  The relationship between irritable bowel syndrome, functional dyspepsia, chronic fatigue and overactive bladder syndrome: a controlled study 6 years after acute gastrointestinal infection.

Authors:  Robert Persson; Knut-Arne Wensaas; Kurt Hanevik; Geir Egil Eide; Nina Langeland; Guri Rortveit
Journal:  BMC Gastroenterol       Date:  2015-06-10       Impact factor: 3.067

10.  Susceptibility to Campylobacter infection is associated with the species composition of the human fecal microbiota.

Authors:  Johan Dicksved; Patrik Ellström; Lars Engstrand; Hilpi Rautelin
Journal:  mBio       Date:  2014-09-16       Impact factor: 7.867
View more
  7 in total

Review 1.  Global burden of irritable bowel syndrome: trends, predictions and risk factors.

Authors:  Christopher J Black; Alexander C Ford
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-15       Impact factor: 46.802

2.  Functional Dyspepsia, Peptic Ulcer, and Helicobacter pylori Infection in a Rural Community of South Asia: An Endoscopy-Assisted Household Survey.

Authors:  M Masudur Rahman; Uday C Ghoshal; Md Golam Kibria; Nigar Sultana; M Abdllah Yusuf; Shamsun Nahar; Faruque Ahmed; Ahm Rowshon; Mahmud Hasan
Journal:  Clin Transl Gastroenterol       Date:  2021-04-16       Impact factor: 4.396

3.  Post-infection functional gastrointestinal disorders following coronavirus disease-19: A case-control study.

Authors:  Uday C Ghoshal; Ujjala Ghoshal; M Masudur Rahman; Akash Mathur; Sushmita Rai; Mahfuza Akhter; Tanvir Mostafa; Mohammad Shohidul Islam; Sheikh Ahmedul Haque; Ankita Pandey; Md Golam Kibria; Faruque Ahmed
Journal:  J Gastroenterol Hepatol       Date:  2021-11-04       Impact factor: 4.369

Review 4.  Postinfection Irritable Bowel Syndrome.

Authors:  Uday C Ghoshal
Journal:  Gut Liver       Date:  2022-05-15       Impact factor: 4.519

Review 5.  Irritable bowel syndrome and microbiome; Switching from conventional diagnosis and therapies to personalized interventions.

Authors:  Pouyan Ghaffari; Saeed Shoaie; Lars K Nielsen
Journal:  J Transl Med       Date:  2022-04-11       Impact factor: 5.531

6.  Colonic Gene Expression and Fecal Microbiota in Diarrhea-predominant Irritable Bowel Syndrome: Increased Toll-like Receptor 4 but Minimal Inflammation and no Response to Mesalazine.

Authors:  Jonna Jalanka; Ching Lam; Andrew Bennett; Anna Hartikainen; Fiona Crispie; Laura A Finnegan; Paul D Cotter; Robin Spiller
Journal:  J Neurogastroenterol Motil       Date:  2021-04-30       Impact factor: 4.924

Review 7.  Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19.

Authors:  Byungchang Jin; Rajan Singh; Se Eun Ha; Hannah Zogg; Paul J Park; Seungil Ro
Journal:  World J Gastroenterol       Date:  2021-05-21       Impact factor: 5.742
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.